It’s a depressingly common aphorism in Washington policy-making circles that “pharma always wins.” This happens regardless of the merits of any particular policy — in fact, the more “pharma always wins,” the more often taxpayers and consumers lose. Nevertheless, the…
As anyone who’s followed the long-standing battle to fix America’s patent system and cut off abuses by bottom-feeding legal parasites and abusive monopolists will tell you, the list of excuses for our broken system offered by those people is seemingly…
America’s pharmaceutical industry has a problem, and that problem is the rule of law. One can draw no other conclusion, based on the industry’s recent actions. I refer specifically to the pharmaceutical company Allergan’s recent optically baffling attempt to outright…
It is a cliché in Washington that the war on drugs has seen a comeback, thanks almost entirely to the efforts of Attorney General Jeff Sessions. Whether that comeback is as big as advertised is a matter of some debate,…
For months, the pharmaceutical industry’s consistent disregard of consumers and bad press has seemed like a setup that was missing a punchline. Critics of the industry have been consistently frustrated as we wait for the other shoe to drop. These…
The crisis of confidence in the pharmaceutical industry remains one of the least well-reported elements of contemporary politics. And despite numerous scandals surrounding mismanagement and price gouging by Pharma companies, the proverbial big Kahuna of the industry’s scandals is undoubtedly…
“Repeal and replace” as a concept was always elegant, particularly as a campaign slogan. In practice, it is consistently proving itself to be harder than its proponents imagined. As with the AHCA before it, it appears that the Senate bill…
In the past week, two news items came out of the Trump White House that should trouble supporters of the President’s populist agenda, and should send warning bells about the advice that President Trump may be receiving from his inner…
The problems of the U.S. health-care system are mounting. Prices are high. Expenditures are unaffordable. And quality is declining. While something must be done, doing the wrong thing will cause more harm than good. And this is why Mytheos Holt’s editorial on…
With another day, another headline arrives revealing the arrogant, out-of-touch nature of the pharmaceutical industry. Fortunately, this time, the outrage arrives from overseas. Specifically, the UK Independent reports that Aspen Pharmaceuticals, which you might remember for such hits as economically blackmailing the Italian government via…
